iStar Medical has announced positive 5-year results from the STAR-GLOBAL trial evaluating the long-t...

Bausch + Lomb has identified the root cause of a recent voluntary recall of select intraocular lense...

VivaVision Biotech has announced positive topline results from its Phase 2 clinical trial of VVN461,...

Entod Pharmaceuticals has received marketing authorization from the Central Drugs Standard Control O...

Zhaoke Ophthalmology has announced the enrollment of the first patient in its Phase 3 clinical trial...

Microsurgical Technology (MST) has announced a strategic partnership with Japanese manufacturer Mani...

The U.S. Food and Drug Administration (FDA) has accepted Regeneron’s supplemental Biologics License ...

Biocon Biologics has announced a settlement and license agreement with Regeneron, enabling the futur...

Atsena Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has granted Regen...

Eyestem Research has announced encouraging results from its Phase 1 clinical trial (NCT06394232) eva...